(Press-News.org) Dartmouth Institute for Quantitative Biomedical Sciences (iQBS) researchers developed a new gene expression analysis approach for identifying cancer genes. The paper entitled, "How to get the most from microarray data: advice from reverse genomics," was published online March 21, 2014 in BMC Genomics. The study results challenge the current paradigm of microarray data analysis and suggest that the new method may improve identification of cancer-associated genes.
Typical microarray-based gene expression analyses compare gene expression in adjacent normal and cancerous tissues. In these analyses, genes with strong statistical differences in expression are identified. However, many genes are aberrantly expressed in tumors as a byproduct of tumorigenesis. These "passenger" genes are differentially expressed between normal and tumor tissues, but they are not "drivers" of tumorigenesis. Therefore, better analytical approaches that enrich the list of candidate genes with authentic cancer-associated "driver" genes are needed.
Lead authors of the study, Ivan P. Gorlov, Ph.D., Associate Professor of Community and Family Medicine and Christopher Amos, Ph.D., Professor of Community and Family Medicine and Director of the Center for Genomic Medicine described a new method to analyze microarray data. The research team demonstrated that ranking genes based on inter-tumor variation in gene expression outperforms traditional analytical approaches. The results were consistent across 4 major cancer types: breast, colorectal, lung, and prostate cancer.
The team used text-mining to identify genes known to be associated with breast, colorectal, lung, and prostate cancers. Then, they estimated enrichment factors by determining how frequently those known cancer-associated genes occurred among the top gene candidates identified by different analysis methods. The enrichment factor described how frequently cancer associated genes were identified compared to the frequency of identification that one could expect by pure chance. Across all four cancer types, the new method of selecting candidate genes based on inter-tumor variation in gene expression outperformed the other methods, including the standard method of comparing mean expression in adjacent normal and tumor tissues. Dr. Gorlov and colleagues also used this approach to identify novel cancer-associated genes.
The authors cite tumor heterogeneity as the most likely reason for the success of their variance-based approach. The method is based on the knowledge that different tumors can be driven by different subsets of cancer genes. By identifying genes with high variation in expression between tumors, the method preferentially identifies genes specifically associated with cancer. This same feature, tumor heterogeneity, may reduce the ability to identify critical gene expression changes when comparing mean gene expression in adjacent tumor and normal tissues, as tumors of the same type may have different sets of genes differentially expressed.
The results of the study challenge the model that comparing mean gene expression in adjacent normal and cancer tissues is the best approach to identifying cancer-associated genes. Indeed, the team identified high variation in adjacent "normal" tissue samples, which are typically used as control samples for comparison in analyses based on mean gene expression. The study suggests that methods based on variance may help get the most from existing and future global gene expression studies.
INFORMATION:
The iQBS, established in July of 2010 to promote interdisciplinary education, research, and infrastructure in the quantitative biomedical sciences, is supported by funds from Dartmouth College, the Geisel School of Medicine, and a Center of Biomedical Research Excellence (COBRE) grant from the Institutional Development Award (IDeA) program of the National Institute for General Medical Sciences (grant P20 GM103534). The iQBS Graduate Program in Quantitative Biomedical Sciences (QBS) prepares students for successful careers in biomedical research and teaching by offering an interdisciplinary Ph.D. degree.
The Center for Genomic Medicine at Dartmouth College, Directed by Christopher Amos, Ph.D., provides support for genomic profiling of patient samples, for the interpretation of findings, and for the design of studies related to personalized medicine.
Novel analyses improve identification of cancer-associated genes from microarray data
2014-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Stem cells from some infertile men form germ cells when transplanted into mice, study finds
2014-05-02
STANFORD, Calif. — Stem cells made from the skin of adult, infertile men yield primordial germ cells — cells that normally become sperm — when transplanted into the reproductive system of mice, according to researchers at the Stanford University School of Medicine and Montana State University.
The infertile men in the study each had a type of genetic mutation that prevented them from making mature sperm — a condition called azoospermia. The research suggests that the men with azoospermia may have had germ cells at some point in their early lives, but lost them as they ...
The Lancet Psychiatry: Reliance on voluntary sector support for suicide bereavement 'unsustainable and inappropriate'
2014-05-02
People bereaved by the suicide of a partner and mothers losing an adult child to suicide run a significantly higher risk of suicide compared to people bereaved after sudden deaths from other causes. The psychological impact on other members of the family is also serious: children who lose a mother to suicide have an increased risk of depression, while people who lose a child to suicide have an increased likelihood of psychiatric admission for mental illness.
The findings come from a new Review, published to coincide with the launch of The Lancet Psychiatry journal, reviewing ...
The Lancet Psychiatry: Around 60 percent of people who contemplate or attempt suicide do not receive treatment
2014-05-02
In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments. Evidence suggests that about 60% of people struggling with suicidal thoughts or behaviour do not receive any help, and, surprisingly, ...
The Lancet Psychiatry: Nationwide study finds US newspaper reporting of suicide linked with some teenage suicide clusters
2014-05-02
Heightened newspaper coverage after a suicide might have a significant impact on the initiation of some teenage suicide clusters, according to new research published in The Lancet Psychiatry journal.
The study reveals that the content of media reports is also important, with more prominent stories (ie, published on the front page) and those that describe the suicide in considerable detail more likely to be associated with so-called copycat suicides.
"Our findings indicate that the more sensational the coverage of the suicides, and the more details the story provides, ...
The Lancet Psychiatry: Promising biomarkers to predict suicide risk
2014-05-02
In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Kees van Heeringen from Ghent University in Belgium and John Mann from Columbia University in the USA discuss the stress-diathesis theory of suicide, in which a predisposition or diathesis interacts with stressful life experiences and acute psychiatric illness to cause suicidal behaviour. The theory explains why only a small minority of individuals are at risk of taking their own lives after exposure to such stressors.
The authors discuss the causes of the diathesis, or ...
Gene discovery links cancer cell 'recycling' system to potential new therapy
2014-05-02
University of Rochester scientists have discovered a gene with a critical link to pancreatic cancer, and further investigation in mice shows that by blocking the gene's most important function, researchers can slow the disease and extend survival.
Published online by Cell Reports, the finding offers a potential new route to intrude on a cancer that usually strikes quickly, has been stubbornly resistant to targeted therapies, and has a low survival rate. Most recent improvements in the treatment of pancreatic cancer, in fact, are the result of using different combinations ...
Blood pressure control, lifestyle changes key to preventing subsequent strokes
2014-05-02
Stroke survivors should control their blood pressure, cholesterol and weight and do moderate physical activity regularly to avoid having another stroke, according to an American Heart Association/American Stroke Association scientific statement.
They should also receive other evidence-based therapy specific to their individual health, which may include aspirin therapy or a surgical procedure to keep neck arteries open.
The statement, "Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack (TIA)," is published in the American Heart ...
Amphibians in a vise: Climate change robs frogs, salamanders of refuge
2014-05-02
By hightailing it to nearby ponds and shallow waterways, frogs and salamanders have – until now – had a way to evade exotic trout introduced to the West's high-mountain lakes for recreational fishing.
A warming climate, however, will dry up some of the places where amphibians and their young have found refuge. Researchers in the May 1 issue of Frontiers in Ecology and the Environment write about this challenge and a novel combination of tools that could help land managers, biologists, fishing enthusiasts and other citizens weigh where amphibians are in the most need of ...
Remodelling damaged nuclei
2014-05-02
Scientists at the University of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing. The results are published in the journal Science.
Around 150 people worldwide are known ...
'Achilles heel' of pancreatic cancer identified
2014-05-02
WASHINGTON — A research team at Georgetown Lombardi Comprehensive Cancer Center reports that inhibiting a single protein completely shuts down growth of pancreatic cancer, a highly lethal disease with no effective therapy.
Their study, to be published May 6th in Science Signaling, demonstrates in animal models and in human cancer cells that while suppressing Yes-associated protein (Yes) did not prevent pancreatic cancer from first developing, it stopped any further growth.
"We believe this is the true Achilles heel of pancreatic cancer, because knocking out Yes crushes ...